课题基金 / 基金详情

Novel markers for tracking early treatment response to rTMS in major depressive disorder

Novel markers for tracking early treatment response to rTMS in major depressive disorder
用于追踪重度抑郁症 rTMS 早期治疗反应的新标记
批准号：
488406
负责人：
Rabin Jennifer S
金额：
$31.77万
依托单位：
Sunnybrook Research Institute (Toronto, Ontario)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2023
资助国家：
加拿大
项目状态：
未结题
起止时间：
2023-09-01 至 2028-09-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=488406&lang=en
关键词：
Behavioural Markers Eye Tracking Major Depressive Disorder Neuromodulation Rtms Speech

项目摘要

项目成果

Rabin Jennifer S的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Major depressive disorder (MDD) is a common and disabling condition. Up to one-third of patients with MDD do not respond to standard treatments, such as medication and therapy. Alternative treatments include direct-to-brain interventions, such as repetiti
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Investigating risk factors for cognitive impairment using precision neuropsychological and neuroimaging measures in a Canadian multi-ethnic cohort
Investigating fornix integrity as a sensitive biomarker in individuals who show the earliest signs of Alzheimer's disease
An fMRI investigation of mental state attributions in healthy and focal lesion patients
  • 批准号：
    184416
  • 项目类别：
    Studentship Programs
  • 资助金额：
    $7.65万
  • 财政年份：
    2008
  • 负责人：
    Rabin Jennifer S
  • 依托单位：
    York University (Toronto, Ontario)
海外基金